CB vs TERN
Chubb Ltd (CB) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CB and TERN stock pages for the full models.
Not investment advice.